Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019
Open accessAbstract
Background: Cardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60–89 years at the global, regional, and national levels in 204 countries from 1990 to 2019. Methods: Detailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%. Results: Globally, there were 475,458 (339,942–638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13–19.3) per 100,000 person-years. And there were 185,308 (154,610–200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7–4.8). CM-MC resulted in 3,372,716 (2,931,247–3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7–126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924–24,241)] and disability-adjusted life years [407,712 (370,234–470,165)]. And China had the highest number of incident cases [122, 266 (85,925–166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths. Conclusion: CM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The latest Global Burden of Disease statistics before the COVID-19 pandemic place the worldwide prevalence of myocarditis and cardiomyopathy at 10.2 to 105.6 cases per 100,000 individuals.
“The latest Global Burden of Disease statistics before the COVID-19 pandemic place the worldwide prevalence of myocarditis and cardiomyopathy at 10.2 to 105.6 cases/100 000 individuals.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [82]
The Introduction identifies GBD 2019 as the most recent data available for cardiomyopathy and myocarditis, supporting the claim’s pre-pandemic data source. But the Abstract Methods and Results report incidence, mortality, and DALYs—not prevalence—and our copy does not give a prevalence range of 10.2–105.6 per 100,000. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 31 · Cited by 12
- Authors
- Zhang, K., Cheng, X., Qu, N., Song, H., Luo, Y., Ye, T., Xu, Q., Tian, H., Kan, C., & Hou, N.
- Affiliations
- Weifang Medical University (CN)
- Corresponding author
- Kan, Chengxia
- Hou, Ningning
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2022-09-23
- Volume
- 10
- Pages
- 1018385-1018385
- ISSN
- 2296-2565 (ISSN-L)
- PMC
- PMC9545016
- OpenAlex
- W4296998303
- Cited by
- 12
- References
- 31
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 2
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81870593, 81870593 and 82170865, 82170865)
- Natural Science Foundation of Shandong Province (ZR2020MH106)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Health Professions › Health Information Management › Global Health and Epidemiology
- Keywords
- cardiomyopathy, myocarditis, older adults, disease burden, incidence, mortality, disability-adjusted life years, risk factors, systolic blood pressure, alcohol consumption, tobacco use, heart failure, global health trends, regional disparities, United States, China
- MeSH terms
- Global Burden of Disease, Aged, Humans, Cardiomyopathies, Myocarditis, Incidence, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
